CME and CFTC Clash Over On-Chain Perpetual Futures

The dispute between the CME Group and the US Commodity Futures Trading Commission (CFTC) has been brewing since the regulator approved the listing of blockchain-based perpetual future products, despite the CME's objections. The CME has sued the CFTC, arguing that these products, known as perps, are harmful to its traditional futures contracts and that the regulator is mislabeling them. The CFTC, on the other hand, claims that its decision to allow perps is a step towards regulating the rapidly growing market. The lawsuit has significant implications for the US approach to the crypto space, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME's CEO, Terry Duffy, has been vocal in his opposition to perps, stating that they are not suitable for institutional clients and that the CFTC's decision did not consider the ramifications. The CFTC's chairman, Mike Selig, has defended the regulator's decision, saying that it is a necessary step towards regulating the market. The case is currently awaiting federal court action, which could have significant influence on the future of the US crypto market.